Головна Спрощенний режим Відео-інструкція Опис
Авторизація
Прізвище
Пароль
 

Бази даних


Періодичні видання- результати пошуку

Вид пошуку

Зона пошуку
Формат представлення знайдених документів:
повнийінформаційнийкороткий
Відсортувати знайдені документи за:
авторомназвоюроком виданнятипом документа
Пошуковий запит: (<.>A=Nazarkina, V. M.$<.>)
Загальна кількість знайдених документів : 4
Показані документи з 1 по 4
1.
Шифр: ВУ18/2017/1
   Журнал

Вісник фармації
2017р. № 1
Зміст:
The synthesis, spectral properties and the biological activity of 7-arenesulfonyl-3-arylmethyl-1,3,7-triazaspiro[4.4]nonane-2,4-dione derivatives. - С.3-9
Інші автори: Krolenko K. Yu., Vlasov S. V., Zhuravel I. O., Osolodchenko T. P.
Oproshanska, T. V. Determination of the quantitative content of the amount of organic acids and ascorbic acid in different batches of Rosa majalis and Rosa canina raw material / T. V. Oproshanska, O. P. Khvorost, L. V. Ocheredko. - С.10-13
The quantitative “structure–antibacterial activity” relationships in a series of N-substituted amino acids. - С.14-20
Інші автори: Golik M. Yu., Kryskiv O. S., Komissarenko A. M., Kolisnyk O. V., Dudka K. I.
The experimental substantiation of the shelf-life of “Candidocyde” vaccine. - С.21-24
Інші автори: Rybalkin M. V., Strilets O. P., Strelnikov L. S., Ivakhnenko O. L.
Substantiation of the choice of components for a combined drug used for the treatment of type 2 diabetes mellitus. - С.25-31
Інші автори: Toraiev K. N., Nemchenko A. S., Tsubanova N. A., Bezchasniuk O. M., Yevsieieva L. V.
Nazarkina, V. M. Substantiation of the model of pricing for essential drugs in the context of the Health Technology Assessments / V. M. Nazarkina. - С.32-37
Kobets, M. M. The subjective assessment of causes of adverse effects of drugs in the population of Ukraine / M. M. Kobets. - С.38-42
Ivko, T. The study of the Ukrainian pharmaceutical market of laxatives / T. Ivko, T. Germanyuk, L. Bobritskaya. - С.43-49
Pharmacoepidemiological analysis of the use of antibacterial drugs in the pulmonary department of the multi-specialty hospital of the Republic of Tajikistan. - С.50-55
Інші автори: Savchenkova L. V., Saidova M. N., Sanginova N. S., Jabarov I. P.
Tolochko, K. V. Analysis of the domestic pharmaceutical market of anthelmintic medicines / K. V. Tolochko, L. I. Vyshnevska. - С.56-60
The study of 2-((3-R-4-R1-4H-1,2,4-triazole-5-yl)thio) acetic acid salts as growth stimulators of winter wheat sprouts. - С.61-65
Інші автори: Shcherbyna R. O., Danilchenko D. M., Khromykh N. O., Lykholat Yu. V.
Є примірники у відділах: всього 1
Вільні: 1

Знайти схожі
Перейти до описів статей

2.


    Nazarkina, V. M.
    Substantiation of the model of pricing for essential drugs in the context of the Health Technology Assessments [Text] / V. M. Nazarkina // Вісн. фармації. - 2017. - № 1. - P32-37


MeSH-головна:
ЭКОНОМИКА ФАРМАЦЕВТИЧЕСКАЯ -- ECONOMICS, PHARMACEUTICAL
ЗДРАВООХРАНЕНИЯ СЛУЖБ ДОСТУПНОСТЬ -- HEALTH SERVICES ACCESSIBILITY (экономика)
Анотація: The problem of availability of drugs can be solved by implementation of effective social and economic mechanisms. Aim. To substantiate theoretically the effective management model of pricing for drugs
Вільних прим. немає

Знайти схожі

3.
Шифр: ВУ18/2017/3
   Журнал

Вісник фармації
2017р. № 3
Зміст:
Tkachenko, P. V. The synthesis and the antimicrobial activity of N1-substituted 5-amino-4-arylsulfonyl-3-N-phenylaminopyrazoles / P. V. Tkachenko [et al.]. - С.3-9
Інші автори: Tkachenko O. V., Netosova K. Yu., Borisov O. V., Zhuravel I. O., Kazmirchuk V. V.
Golik, М. Yu. Molecular parameters and the antimicrobial activity of some N-substituted amino acids / M. Yu. Golik [et al.]. - С.10-15
Інші автори: Kryskiv О. S., Komissarenko A. M., Kolisnyk O. V.
Navruzova, G. F. The study of biologically active substances of the extract obtained from peach leaves of the tajik variety / G. F. Navruzova, V. S. Kyslychenko, L. V. Lenchyk. - С.16-20
Osmachko, А. Р. Carboxylic acids of phenolic complexes from Veronica teucrium L. / A. P. Osmachko [et al.]. - С.21-27
Інші автори: Kovaleva А. М., Ilyina T. V., Koshovyi О. М.
Litvinova, O. M. Development of the laboratory technology of the combined pessaries with acyclovir and essential oils / O. M. Litvinova, Yu. V. Levachkova, V. M. Chushenko. - С.28-33
Petrovska, L. S. Peculiarities of thickening of the modern foam base in the acid medium / L. S. Petrovska, Yu. О. Bezpala, I. I. Baranova. - С.34-38
Nazarkina, V. M. Analysis of modern approaches to formation of cost price for veterinary preparations / V. M. Nazarkina, Zh. M. Polova. - С.39-44
Zarichkova, M. V. The study of the directions for creation of employee benefits for pharmacy professionals and calculation of the possible cost of the individual components (options) / M. V. Zarichkova. - С.45-60
Volkovoy, V. A. The experimental study of the antihypoxic and antioxidant activity of 5,7-dihydro-1H-pyrrolo-[2,3-d]pyrimidine derivatives / V. A. Volkovoy [et al.]. - С.61-65
Інші автори: Sevrukov O. V., Kolisnyk S. V., Derkach N. V., Kryzhna S. I., Ostapets M. O.
Є примірники у відділах: всього 1
Вільні: 1

Знайти схожі
Перейти до описів статей

4.


    Nazarkina, V. M.
    Analysis of modern approaches to formation of cost price for veterinary preparations [Text] / V. M. Nazarkina, Zh. M. Polova // Вісн. фармації. - 2017. - № 3. - P39-44


MeSH-головна:
ВЕТЕРИНАРНЫЕ ЛЕКАРСТВЕННЫЕ СРЕДСТВА -- VETERINARY DRUGS (экономика)
ЭКОНОМИКА ФАРМАЦЕВТИЧЕСКАЯ -- ECONOMICS, PHARMACEUTICAL
Анотація: To analyze the modern approaches to cost accounting and calculation of the cost price of veterinary preparations (VP) in order to increase their economic availability. Materials and methods. The regulatory and legal framework and methodological approaches to formation of the cost of production were analyzed. The production and full costs of VP were calculated in order to substantiate the economic feasibility of their manufacturing. The structure of the cost price of VP was analyzed. Results and discussion. The analysis of the modern approaches to pricing on medicines and VP has been carried out. It has been determined that chemical and pharmaceutical enterprises producing medicines and VP use different approaches when accounting the costs and calculating the cost price; as a result, it has a significant impact on the level of prices and the structure of the cost price. The project cost of three new antimastitis VP in the form of cream, solution and spray has been calculated using two different methods. The calculations performed confirm the economic feasibility of introduction of VP into production. Conclusions. Antimastitis products proposed for introduction into production are price competitive. The efficient cost management of VP will allow gaining competitive advantages at the market and providing their economic availability
Дод.точки доступу:
Polova, Zh. M.

Вільних прим. немає

Знайти схожі

 
© Міжнародна Асоціація користувачів і розробників електронних бібліотек і нових інформаційних технологій
(Асоціація ЕБНІТ)